許 軒豪

Medicine & Life Sciences

1. Urachal cancer 100%
2. Testicular Germ Cell Tumor 79%
3. Intravesical Administration 78%
4. Urinary Bladder Neoplasms 68%
5. Neurilemmoma 66%
6. Mitomycin 63%
7. Urinary Incontinence 62%
8. Hemangioma 61%
9. Prostate-Specific Antigen 58%
10. Drug Therapy 56%
11. Vitamin D 53%
12. Renal Insufficiency 50%
13. Sepsis 46%
14. Urinary Bladder 45%
15. Seizures 44%
16. Fever 43%
17. Meta-Analysis 42%
18. Recurrence 41%
19. Transplants 35%
20. Brain Neoplasms 35%
21. Hematuria 30%
22. Brain 28%
23. Radiotherapy 26%
24. Serum 26%
25. Neoplasm Metastasis 23%
26. Urachus 22%
27. Neoplasms 22%
28. Hot Temperature 22%
29. Dialysis 21%
30. Conservative Treatment 20%
31. Residual Neoplasm 20%
32. Coma 20%
33. Cohort Studies 19%
34. Prostate 19%
35. Cross-Sectional Studies 18%
36. Tumor Biomarkers 18%
37. Cavernous Hemangioma 18%
38. Bibliographies 16%
39. Vitamin D Deficiency 16%
40. Male Genitalia 14%
41. Survival Rate 14%
42. Survivorship 13%
43. Kidney 13%
44. Lymph Nodes 13%
45. Symptom Flare Up 13%
46. Hepatitis C 13%
47. Patient Preference 12%
48. Libraries 12%
49. Databases 12%